Open access
Open access
Powered by Google Translator Translator

Covid-19

WHO lists Moderna vaccine for emergency use

4 May, 2021 | 08:49h | UTC

WHO lists Moderna vaccine for emergency use – World Health Organization

 


COVID studies note online learning stress, fewer cases in schools with protocols

4 May, 2021 | 08:47h | UTC

COVID studies note online learning stress, fewer cases in schools with protocols – CIDRAP

Study 1: COVID-19 Infections Among Students and Staff in New York City Public Schools – Pediatrics

Study 2:  Household COVID-19 risk and in-person schooling – Science

Study 3: Caregiver Perceptions of Children’s Psychological Well-being During the COVID-19 Pandemic – JAMA Network Open AND Editorial: It Is Time to End the Debate Over School Reopening

 


WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines

4 May, 2021 | 08:49h | UTC

WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines – Health Policy Watch

 


[Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload situations emerge, will improve patient outcomes”

4 May, 2021 | 08:42h | UTC

Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – medRxiv

 


Novel coronavirus really is seasonal, study suggests

4 May, 2021 | 08:46h | UTC

Novel coronavirus really is seasonal, study suggests – LiveScience

Original study: Climate and the spread of COVID-19 – Scientific Reports

 


[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

4 May, 2021 | 08:44h | UTC

Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – medRxiv

Commentary: Study finds one-third of COVID-19 patients experience neurological symptoms – News Medical

 


M-A: Tocilizumab reduces the need for mechanical ventilation in COVID-19 patients, but the randomized trials included in the analysis showed it has no significant effect on the risk of mortality or adverse events

3 May, 2021 | 05:44h | UTC

Efficacy and safety of tocilizumab in COVID-19 patients: A living systematic Review and meta-analysis: first update – Clinical Microbiology and Infection

 


Report: The Epidemics that Didn’t Happen – The lessons that can be learned from epidemics that were contained

3 May, 2021 | 05:41h | UTC

The Epidemics that Didn’t Happen – Prevent Epidemics

Commentaries: ‘The next big one must be prevented’: The lessons the world can learn from epidemics that were contained – STAT AND Former CDC director: We can prevent the next pandemic – CNN AND Learning from the “Near Misses” – Global Health NOW

 


RECOVERY trial: In hospitalized COVID-19 patients with hypoxia and systemic inflammation (C-reactive protein ≥75 mg/L), tocilizumab improved survival and other clinical outcomes

3 May, 2021 | 05:47h | UTC

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Invited commentary: Tocilizumab in COVID-19: some clarity amid controversy – The Lancet

 


Shift work is associated with positive COVID-19 status in hospitalized patients

3 May, 2021 | 05:36h | UTC

Shift work is associated with positive COVID-19 status in hospitalised patients – Thorax

Commentary: Shift Work Linked to Increased Risk for COVID-19 Illness – HealthDay

 


[Preprint] Estimating the early impact of immunization against COVID-19 on deaths among older adults in Brazil

3 May, 2021 | 05:38h | UTC

Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality. – medRxiv

 

Commentary on Twitter (thread – click for more)

https://twitter.com/hildabast/status/1388290899029938179

 


Analysis: Why is India having a covid-19 surge?

3 May, 2021 | 05:39h | UTC

Why is India having a covid-19 surge? – The BMJ

See also: India Is Counting Thousands Of Daily COVID Deaths. How Many Is It Missing? – NPR AND Opinion: India’s covid-19 crisis is a dire warning for all countries – The Washington Post AND India’s nightmare: Record high cases, vaccine shortages, hospital fires. – The New York Times AND India coronavirus: New record deaths as virus engulfs India – BBC

 


M-A: The viral shedding time (VST) determines disease transmission and the duration of infectiousness in SARS-CoV-2 infections – this study found that symptomatic infections, infected adults, persons with chronic diseases, and persons receiving corticosteroid treatment have longer VST

3 May, 2021 | 05:37h | UTC

Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis – Frontiers in Public Health

 


Case series of 12 patients with cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination – all women younger than 60 years, with symptoms from 6 to 15 days after vaccination

3 May, 2021 | 05:43h | UTC

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 – JAMA

Editorial: Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine – JAMA

See also: Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 – Centers for Disease Control and Prevention AND Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 – Centers for Disease Control and Prevention

Related: AHA/ASA Guidance: Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – “No heparin products in any dose should be given.”

 


AHA/ASA Guidance: Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – “No heparin products in any dose should be given.”

30 Apr, 2021 | 08:25h | UTC

Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – Stroke

News release: Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine – American Heart Association

Related: ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia

 


Study with 6.9 million people in England shows severe Covid-19 in young people can mostly be explained by obesity – At a BMI of more than 23 kg/m2, there was a linear increase in risk of severe COVID-19

30 Apr, 2021 | 08:22h | UTC

Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study – The Lancet Diabetes & Endocrinology

Commentaries: Severe COVID in young people can mostly be explained by obesity – new study – The Conversation AND Obesity studies highlight severe COVID outcomes, even in young adults – CIDRAP AND Expert reaction to study looking at a potential link between body weight and risk of severe COVID-19, especially for younger adults – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


Debate: Should masks be worn outdoors?

30 Apr, 2021 | 08:21h | UTC

Should masks be worn outdoors? – The BMJ

Commentaries: Experts debate on wearing masks outdoors – News Medical AND Do masks need to be worn outdoors? – Advanced Science News

 

Commentary on Twitter (thread – click for more)

 


Cohort study: Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes – “although babies born of test-positive mothers are more likely to be born early, extremely few were infected with COVID-19”

30 Apr, 2021 | 08:17h | UTC

Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes – JAMA

News release: Low risk of infection in babies born to mothers with COVID-19 – Karolinska Institutet

Editorial: Understanding Risk for Newborns Born to SARS-CoV-2–Positive Mothers – JAMA

 

Commentary on Twitter

 


Household COVID-19 risk and in-person schooling – “While in-person schooling is associated with household COVID-19 risk, this risk can likely be controlled with properly implemented school-based mitigation measures”

30 Apr, 2021 | 08:19h | UTC

Household COVID-19 risk and in-person schooling – Science

News Release: In-Person Schooling with Inadequate Mitigation Measures Raises Household Member’s COVID-19 Risk – Johns Hopkins Bloomberg School of Public Health

 

Commentary on Twitter

 


Opinion | The world could be doing much more to help India: Countries can’t go it alone in tackling Covid-19

30 Apr, 2021 | 08:16h | UTC

The world could be doing much more to help India – Vox

See also: WHO provides update on India’s surging epidemic second wave and variant B.1.617 – Science Speaks: Global ID News AND People Are Talking About A ‘Double Mutant’ Variant In India. What Does That Mean? – NPR AND WHO says India COVID crisis could ‘happen anywhere’ – MedicalXpress AND India’s COVID-19 Crisis Is Spiraling Out of Control. It Didn’t Have to Be This Way – TIME

 


‘Unprecedented achievement’: who received the first billion COVID vaccinations?

30 Apr, 2021 | 08:14h | UTC

‘Unprecedented achievement’: who received the first billion COVID vaccinations? – Nature

 


Opinion | SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

30 Apr, 2021 | 08:12h | UTC

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties – The Lancet

 

Counterpoint: Commentary on Twitter (thread – click for more)

 


COVID-19 ‘brain fog’ inspires search for causes and treatments

30 Apr, 2021 | 08:13h | UTC

COVID-19 ‘brain fog’ inspires search for causes and treatments – Science (a few articles per month are free)

 


Study in England showed one dose of COVID-19 vaccine can cut household transmission by up to half – This protection is on top of the reduced risk of a vaccinated person developing symptomatic infection, which is around 60 to 65% after the first dose

29 Apr, 2021 | 08:44h | UTC

News release: One dose of COVID-19 vaccine can cut household transmission by up to half – Public Health England

Original study (preprint): Impact of vaccination on household transmission of SARS-COV-2 in England – Public Health England

Commentaries: Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows – The BMJ AND Covid: One dose of vaccine halves transmission – study – BBC

 


Opinion | A global pandemic treaty should aim for deep prevention

30 Apr, 2021 | 08:11h | UTC

A global pandemic treaty should aim for deep prevention – The Lancet

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.